Dominick C. Colangelo's holdings in Vericel Corporation are notable. His stock options reflect a significant investment in the company’s future. In 2018 alone, he was granted 300,000 stock options, emphasizing alignment with shareholder interests. These options, granted at $7.20 per...
Dominick C. Colangelo's holdings in Vericel Corporation are notable. His stock options reflect a significant investment in the company’s future. In 2018 alone, he was granted 300,000 stock options, emphasizing alignment with shareholder interests. These options, granted at $7.20 per share, could be a lucrative asset if the stock price performs well. In past years, his holdings have seen fluctuations, with peak values tied to his earlier options granted in 2013, when he had over 55,000 shares vesting, demonstrating both risk and potential during his tenure. As of early 2019, the value of his exercised options exceeded $2 million, indicating his proactive approach has been fruitful. Colangelo has consistently placed substantial value in company stock, showcasing his commitment to Vericel's mission.